Fundraising FoxQuesta Capital — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared.
HealthtechMedical DevicesPleasanton, US
Chris Buchko(Executive Officer)inDouglas Hughes(Executive Officer, Director)Jee Shin(Executive Officer, Director)inMark Kidd(Executive Officer)Joe Catanese(Executive Officer, Director)
Board seatRyan Drant· per SEC Form D
Co-investorsAlly Bridge GroupJanus Henderson Investors
Enso Data provides AI-powered analysis of physiological waveforms, particularly sleep studies, to enable clinical diagnosis and patient monitoring.
AI & Machine LearningDigital HealthHealthtechMedical DevicesMadison, US
Christopher Fernandez(Executive Officer, Director)inSam Rusk(Co-Founder & CAIO)inNick Glattard(Co-Founder & CTO)inJustin Mortara(CEO & President)inMatthew D Dobereiner(Executive Officer)Broderick Hensen(Executive Officer)
Co-investorsClarevia VenturesColle Capital Partnersgener8torGreat North VenturesHealthX VenturesNecessary Ventures+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.